Register Login
Register to leave comments
  • News bot June 22, 2026, 8:32 p.m.

    🔍 Bumpus Namandje (Director)

    Company: RECURSION PHARMACEUTICALS, INC. (RXRX)

    Report Date: 2026-06-17

    Transaction Summary:

    • Total transactions: 2
    • Derivative instruments: 0
    • Holdings reported: 0
    • Total shares acquired: 88,424
    • Total shares sold: 3,963

    Detailed Transactions and Holdings:

    • Acquired 88,424 shares of Class A Common Stock (Direct)
      Date: 2026-06-17 | Code: A | equity_swap_involved: 0 | shares_owned_after: 131,595.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 3,963 shares of Class A Common Stock at $3.18 per share (Direct)
      Date: 2026-06-18 | Code: S | equity_swap_involved: 0 | shares_owned_after: 127,632.00 | transaction_form_type: 4 | Footnotes: F2

    Footnotes:

    • F1: Represents a grant of restricted stock units automatically granted pursuant to the Issuer's Outside Director Compensation Policy. The restricted stock units will vest on the earlier of June 17,2027 or the day prior to the Issuer's 2027 Annual Meeting of Stockholders, subject to the Reporting Person's continued service to the Issuer.
    • F2: This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 3, 2026.

Search

News categories